{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:08:18Z","timestamp":1770217698033,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00228-013-1608-3","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T09:34:56Z","timestamp":1385372096000},"page":"261-263","source":"Crossref","is-referenced-by-count":19,"title":["Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy"],"prefix":"10.1007","volume":"70","author":[{"given":"Nadav","family":"Willner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Storch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Tadmor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elad","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cpt1973144part1572","volume":"14","author":"DH Huffman","year":"1973","unstructured":"Huffman DH, Wan SH, Azarnoff DL et al (1973) Pharmacokinetics of methotrexate. Clin Pharmacol Ther 14:572\u2013579","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1608_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/08860220500461328","volume":"28","author":"CP Yang","year":"2006","unstructured":"Yang CP, Kuo MC, Guh JY, Chen HC (2006) Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature. Ren Fail 28(1):95\u201397","journal-title":"Ren Fail"},{"key":"1608_CR3","first-page":"1424","volume":"26","author":"M Nakamura","year":"1999","unstructured":"Nakamura M, Sakemi T, Nagasawa K (1999) Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis. J Rheumatol 26:1424\u20131425","journal-title":"J Rheumatol"},{"key":"1608_CR4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ndt\/16.5.1087","volume":"16","author":"H Boulanger","year":"2001","unstructured":"Boulanger H, Launay-Vacher V, Hierniaux P, Fau JB, Deray G (2001) Severe methotrexate intoxication in a hemodialysis patient treated for rheumatoid arthritis. Nephrol Dial Transplant 16:1087","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1608_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/RHU.0b013e3181a61f2d","volume":"15","author":"K Cheung","year":"2009","unstructured":"Cheung K, Chow KM, Szeto CC, Tai MH, Kwan BC, Li PK (2009) Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate. J Clin Rheumatol 15(4):177\u2013180","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"1608_CR6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.AOG.0000172374.72125.3e","volume":"107","author":"H Kelly","year":"2006","unstructured":"Kelly H, Harvey D, Moll S (2006) A cautionary tale: fatal outcome of methotrexate therapy given for management of ectopic pregnancy. Obstet Gynecol 107(2):439\u2013441","journal-title":"Obstet Gynecol"},{"key":"1608_CR7","first-page":"1275","volume-title":"The pharmacological basis of therapeutics","author":"P Calabresi","year":"1990","unstructured":"Calabresi P, Chabner BA (1990) Antineoplastic agents, chapter 52. In: Gilman A, Goodman LS, Goodman A (eds) The pharmacological basis of therapeutics, 8th edn. Macmillan, New York, pp 1275\u20131276","edition":"8"},{"key":"1608_CR8","first-page":"370","volume":"3","author":"E Frei 3rd","year":"1980","unstructured":"Frei E 3rd, Blum RH, Pitman SW et al (1980) High dose methotrexate with leucovorin rescue: rationale and spectrum of antitumor activity. Am J Med 3:370\u2013376","journal-title":"Am J Med"},{"key":"1608_CR9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s002800050528","volume":"38","author":"AH Thomson","year":"1996","unstructured":"Thomson AH, Daly M, Knepil J, Harden P, Symonds P (1996) Methotrexate removal during haemodialysis in a patient with advanced laryngeal carcinoma. Cancer Chemother Pharmacol 38:566\u2013570","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"1608_CR10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/WNL.58.10.1513","volume":"58","author":"AJ Ferreri","year":"2002","unstructured":"Ferreri AJ, Reni M, Pasini F et al (2002) A multicenter study of treatment of primary CNS lymphoma. Neurology 58(10):1513\u20131520","journal-title":"Neurology"},{"key":"1608_CR11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.1780330724","volume":"33","author":"MH Ellman","year":"1990","unstructured":"Ellman MH, Ginsberg D (1990) Low-dose methotrexate and severe neutropenia in patients undergoing renal dialysis. Arthritis Rheum 33:1060\u20131061","journal-title":"Arthritis Rheum"},{"key":"1608_CR12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/ndt\/17.3.530","volume":"17","author":"C Basile","year":"2002","unstructured":"Basile C, Montanaro A, Semeraro A (2002) Should low dose methotrexate therapy be prescribed to dialysis patients? Nephrol Dial Transplant 17:530\u2013531","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1608_CR13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0305-7372(95)90010-1","volume":"21","author":"PE Kintzel","year":"1995","unstructured":"Kintzel PE, Dorr RT (1995) Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treat Rev 21(1):33\u201364","journal-title":"Cancer Treat Rev"},{"key":"1608_CR14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00467-002-0946-7","volume":"17","author":"JM Saland","year":"2002","unstructured":"Saland JM, Leavey PJ, Bash RO et al (2002) Effective removal of methotrexate by highflux hemodialysis. Pediatr Nephrol 17:825\u2013829","journal-title":"Pediatr Nephrol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-013-1608-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-013-1608-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-013-1608-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:49:06Z","timestamp":1558702146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-013-1608-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s00228-013-1608-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}